Comparative Effect of Active Release Technique and Myofascial Release in Cervical Myofascial Syndrome
Comparative Effect of Active Release Technique and Myofascial Release to Improve Asthenopia, Sleep and Stress in Patients With Cervical Myofascial Pain Syndrome
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Detaillierte Beschreibung
A musculoskeletal condition known as myofascial pain is characterized by discomfort in the region of a muscle and the fascia, the connective tissue that surrounds it. In addition to having several trigger sites, the pain may be local or widespread. Trigger points are very sensitive muscle foci that radiate pain to the surrounding area and hurts to touch. In particular, the rhomboids, trapezius, levator scapulae, supraspinatus, and infraspinatus often affected muscles in the cervical area. Acute or chronic pain is possible, and it is most likely brought on by overuse, altered posture, or muscular injury. Cervical myofascial pain is highly prevalent globally. A 2021 study by Kamran Ezzati found that 88.9% of Iranian participants had at least one neck trigger point. Similarly, a 2024 study by Sahib Rehman et al in Pakistan reported high prevalence of Myofascial Trigger Points in cervical radiculopathy patients, with mean scores of MTrPs.
Cervical myofascial pain or neck muscle pain is often caused by poor posture or prolonged use of electronic devices, leading to muscle knots or trigger points. A component of myofascial pain is the emotional stress we carry which contributes to muscle tension (in the form of, increased activation of the "fight or flight" response) releasing stress hormones like cortisol that increase muscle tension. As a health care profession, we know that physical injuries like whiplash cause damage to the structures of the neck and may also alter how certain structures respond post injury (inflammation and stiffness). There are many other conditions, such as degenerative disc disease, osteoarthritis, and fibromyalgia, both predispose the patient to altered spinal posture. As a result, muscle may function differently resulting in myofascial pain Cervical myofascial pain can be managed with orthopedic manual techniques like Active Tissue Release (ATR) and Myofascial Release (MFR). ATR, developed by Dr. Michael Leahy, combines pressure with movement to break down adhesions, improve circulation, and reduce trigger point activity. It helps restore muscle balance and relieve postural strain. MFR, popularized by John F. Barnes, uses gentle sustained pressure to release fascial restrictions, improve blood flow, and reduce nervous system overactivity. Both techniques enhance mobility, reduce pain, and promote better posture and function in the neck.
Combining these interventions with eye exercises targets both neuromuscular and visual dysfunction, offering a holistic approach to improving sleep quality, reducing stress, and alleviating cervical pain. The study addresses a gap in evidence by directly comparing ART and MFR with integrated eye exercises, potentially guiding physiotherapists and clinicians toward the most effective treatment strategy for CMPS.
Studientyp
Studientyp
Einschreibung (Geschätzt)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
Studienkontakt
- Name: KINZA ANWAR, MS-OMPT
- Telefonnummer: +92-3239735427
- E-Mail: kinza.anwar@riphah.edu.pk
Studienorte
-
-
Punjab Province
-
Rawalpindi, Punjab Province, Pakistan, 46600
- Railway General Hospital, Rawalpindi
-
Kontakt:
- KINZA ANWAR, MS-OMPT
- Telefonnummer: +92-3239735427
- E-Mail: kinza.anwar@riphah.edu.pk
-
Kontakt:
- IQRA, MS-OMPT*
- Telefonnummer: IFTIKHAR
-
Unterermittler:
- IQRA iFTIKHAR, MS-OMPT*
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
• Both genders
- Age between 18 and 40 years
- Neck pain since last month with NPRS >3
- Cervical Myofascial pain (Presence of one or more trigger point in neck/ shoulder muscles particularly (upper trapezius, SCM and levator)
- PSQI score > 5
- Subjects with ASQ-17 score > 13
Exclusion Criteria:
• Subjects with a history of cervical trauma or surgery
- Subjects with a history of substance abuse
- Subjects with use of sleep medications
- Subjects with psychological disturbance (stress, depression or anxiety)
- Visual impairment or ophthalmologic disease other than asthenopia
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Sonstiges: Active Release Technique + Eye exercises
|
ART applied to cervical region (upper trapezius, Levator scapula and SCM) deep tension stretch with thumb over the tender areas , repeated 3-5 times. Frequency: 3 days/week for 4 weeks Followed by Eye exercises (3 days/week for 4 weeks)
|
|
Sonstiges: Myofascial Release + Eye exercises
|
|
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
: Neck Disability Index (NDI)
Zeitfenster: Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
The Neck impairment Index (NDI) is a self-report questionnaire designed to measure the self-rated impairment of patients with neck pain and to establish how neck pain impacts a patient's everyday life.
A vertical scale from 0 to 5 is used to rate the questions; After scoring, 0-4 points (0-8%) indicate no disability, 5-14 points (10-28%) indicate mild disability, 15-24 points (30-48%) indicate moderate disability, 25-34 points (50-64%) indicate severe disability, and 35-50 points (70-100%) indicate complete disability
|
Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
|
Numeric Pain Rating Scale NPRS
Zeitfenster: Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
The numeric pain rating scale (NPRS) is a tool used to assess pain intensity, where patients rate their pain on a scale of 0 to 10, with 0 representing no pain and 10 representing the worst possible pain.
|
Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
|
Pittsburgh Sleep Quality Index (PSQI)
Zeitfenster: Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
The Pittsburgh Sleep Quality Index (PSQI) is a standardized questionnaire used to assess sleep quality and disturbances over a one-month period.
It consists of 19 self-rated questions grouped into seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction.
a global score ranging from 0 to 21.
A global PSQI score greater than 5 indicates poor sleep quality, while a score of 5 or below reflects good sleep quality.
|
Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
|
ASQ-17 (Asthenopia Survey Questionnaire)
Zeitfenster: Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
The ASQ-17 (Asthenopia Survey Questionnaire) is a self-administered questionnaire that measures asthenopia (or eye strain) and associated symptoms.
The ASQ-17 covers 7 items of eye strain symptoms, 6 items of visual symptoms and 4 items of systemic and psychological symptoms with a maximum total score of 51 and an optimal cut-off threshold value of 12.5, indicating the presence of asthenopia.
|
Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
|
Perceived Stress Scale (PSS)
Zeitfenster: Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
The Perceived Stress Scale (PSS) is a widely used psychological instrument designed to measure the degree to which individuals perceive their lives as stressful.
The scale typically includes 10 items (PSS-10), yielding a total score ranging from 0 to 40.
Scoring involves reversing the scores for positively worded items (items 4, 5, 7, and 8), then summing all item scores.
Interpretation of scores is generally categorized as follows: 0-13 indicates low stress, 14-26 suggests moderate stress, and 27-40 reflects high perceived stress.
Higher scores indicate greater levels of perceived stress.
|
Baseline, 2 weeks and 4 weeks (one-month follow-up)
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Ermittler
Ermittler
- Hauptermittler: KINZA ANWAR, MS-OMPT, Riphah International University
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Geschätzt)
Studienbeginn
Primärer Abschluss (Geschätzt)
Primärer Abschluss
Studienabschluss (Geschätzt)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Neurologische Manifestationen
- Augenkrankheiten
- Pathologische Zustände, Anzeichen und Symptome
- Anzeichen und Symptome
- Schmerzen
- Asthenopie
- Therapeutika
- Komplementäre Therapien
- Physiotherapiemodalitäten
- Rehabilitation
- Therapie, Weichgewebe
- Muskuloskelettmanipulationen
- Massage
- Myofasziale Freisetzungstherapie
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- Iqra Iftikhar
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .